Health Products Type I ? Class 1/Type I = High risk (serious health hazard). Class 2/Type II = Moderate risk. Class 3/Type III = Low risk. Updated 2026-01-13

Octreotide for injectable suspension; Good manufacturing practices concerns

See all recalls from Octreotide →
Share: Facebook X / Twitter WhatsApp

Recalled Product

Octreotide for injectable suspension


✅ What Should You Do?

  1. 🛑 Stop using this product immediately and set it aside.
  2. If you have an affected product, do not use it.
  3. 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
  4. 📋 Report an adverse reaction to Health Canada MedEffect
Looking for a safe alternative? Search Amazon Canada for Octreotide for injectable suspension →

Hazard / Issue

Product quality

Issued by

Drugs and health products

⚠️ What You Should Do

If you have an affected product, do not use it. Speak to your health care professional immediately to obtain an alternative or replacement product. If you are unsure whether your product is affected, check with your pharmacy.Seek medical attention if you have used this product and are experiencing symptoms of infection, or other unexpected symptoms or side effects.Return affected product(s) to the pharmacy where it was purchased for proper disposal.Consult a health care professional if you have used the affected product and have health concerns.Contact Teva Canada Limited by calling toll-free at 1-800-268-4127, option 3, or by email at druginfo@tevacanada.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.
View official government recall